Clinical impact of Fn-induced high expression of KIR2DL1 in CD8 T lymphocytes in oesophageal squamous cell carcinoma

Clinical impact of Fn-induced high expression of KIR2DL1 in CD8 T lymphocytes in oesophageal squamous cell carcinoma

Background To analyze the correlation between the inducing effect of Fusobacterium nucleatum (Fn) on the surface expression of the inhibitory receptor KIR2DL1 on CD8+ T cells in oesophageal squamous cell carcinoma (ESCC) and the clinicopathological features and survival prognosis and to explore its...

Full description

Bibliographic Details
Main Authors:	Xiaopeng Wang, Yiwen Liu, Yannan Lu, Simo Chen, Yaoping Xing, Haijun Yang, Xiaojun Wang, Yaowen Zhang, Tao Pan, Junkuo Li, Min Wang, Ning Zhang, Mengxia Liang, Fuyou Zhou
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2022-12-01
Series:	Annals of Medicine
Subjects:	fusobacterium nucleatum oesophageal squamous cell carcinomas cd8+ t lymphocytes kir2dl1 prognosis
Online Access:	http://dx.doi.org/10.1080/07853890.2021.2016942

Similar Items

Fusobacterium nucleatum induces MDSCs enrichment via activation the NLRP3 inflammosome in ESCC cells, leading to cisplatin resistance
by: Mengxia Liang, et al.
Published: (2022-12-01)

KIR2DL4 (CD158d): An activation receptor for HLA-G
by: Sumati eRajagopalan, et al.
Published: (2012-08-01)

Abundant CpG-sequences in human genomes inhibit KIR3DL2-expressing NK cells
by: Jason Pugh, et al.
Published: (2021-11-01)

Novel Approach to Cell Surface Discrimination Between KIR2DL1 Subtypes and KIR2DS1 Identifies Hierarchies in NK Repertoire, Education, and Tolerance
by: Jean-Benoît Le Luduec, et al.
Published: (2019-04-01)

Roles of HLA-G/KIR2DL4 in Breast Cancer Immune Microenvironment
by: Guoxu Zheng, et al.
Published: (2022-02-01)

Osteomyelitis of a long bone due to <it>Fusobacterium nucleatum</it> and <it>Actinomyces meyeri</it> in an immunocompetent adult: A case report and literature review
by: Lee Min, et al.
Published: (2012-07-01)

Interaction between human leukocyte antigen (HLA-C) and killer cell Ig-like receptors (KIR2DL) inhibits the cytotoxicity of natural killer cells in patients with hepatoblastoma
by: Jing-Jie Guo, et al.
Published: (2022-11-01)

Fusobacterium nucleatum: from a classic periodontal pathogen to a complete participant of carcinogenesis
by: Kaiumov K.A., et al.
Published: (2023-03-01)

Comparative evaluation of changes in microflora in delayed and immediate implant placement: An In vivo study
by: Shivendra Choudhary, et al.
Published: (2021-01-01)

KIR3DL3-HHLA2 and TMIGD2-HHLA2 pathways: The dual role of HHLA2 in immune responses and its potential therapeutic approach for cancer immunotherapy
by: Yang Li, et al.
Published: (2023-05-01)

Global Investigations of Fusobacterium nucleatum in Human Colorectal Cancer
by: Seul A. Lee, et al.
Published: (2019-07-01)

Metformin elicits antitumour effect by modulation of the gut microbiota and rescues Fusobacterium nucleatum-induced colorectal tumourigenesis
by: Xiaowen Huang, et al.
Published: (2020-11-01)

Non-Expressed Donor KIR3DL1 Alleles May Represent a Risk Factor for Relapse after T-Replete Haploidentical Hematopoietic Stem Cell Transplantation
by: Nolwenn Legrand, et al.
Published: (2023-05-01)

The Interaction of HLA-C1/KIR2DL2/L3 Promoted KIR2DL2/L3 Single-Positive/NKG2C-Positive Natural Killer Cell Reconstitution, Raising the Incidence of aGVHD after Hematopoietic Stem Cell Transplantation
by: Wei Zuo, et al.
Published: (2022-04-01)

<italic toggle="yes">Fusobacterium</italic> Genomics Using MinION and Illumina Sequencing Enables Genome Completion and Correction
by: S. Michelle Todd, et al.
Published: (2018-08-01)

FusoPortal: an Interactive Repository of Hybrid MinION-Sequenced <italic toggle="yes">Fusobacterium</italic> Genomes Improves Gene Identification and Characterization
by: Blake E. Sanders, et al.
Published: (2018-08-01)

Sodium New Houttuyfonate Inhibits Cancer-Promoting <i>Fusobacterium nucleatum (Fn)</i> to Reduce Colorectal Cancer Progression
by: Fengjing Jia, et al.
Published: (2022-12-01)

Haplotype Motif-Based Models for KIR-Genotype Informed Selection of Hematopoietic Cell Donors Fail to Predict Outcome of Patients With Myelodysplastic Syndromes or Secondary Acute Myeloid Leukemia
by: Johannes Schetelig, et al.
Published: (2021-01-01)

Gut Microbiome and Colorectal Cancer
by: Tae-Geun Gweon
Published: (2023-08-01)

A new model of in vitro dentin intratubular contamination for Fusobacterium nucleatum: Validation by confocal laser scanning microscopy
by: Mirela Cesar Barros, et al.
Published: (2023-07-01)

Fecal Fusobacterium nucleatum for the diagnosis of colorectal tumor: A systematic review and meta‐analysis
by: Xinyu Zhang, et al.
Published: (2019-02-01)

Fusobacterium nucleatum supresses anti-tumor immunity by activating CEACAM1
by: Chamutal Gur, et al.
Published: (2019-06-01)

Brain abscess and periodontal pathogens (Fusobacterium Nucleatum). Report of a case
by: Debora Franceschi, et al.
Published: (2020-12-01)

Fusobacterium Nucleatum Empyema: An Atypical Presentation
by: Lucía Barrera López, et al.
Published: (2020-04-01)

Presence of KIR2DL2/S2, KIR2DL5, and KIR3DL1 Molecules in Liver Transplant Recipients with Alcoholic Cirrhosis Could Be Implicated in Death by Graft Failure
by: Raquel Morales, et al.
Published: (2023-03-01)

Corrigendum: Haplotype Motif-Based Models for KIR-Genotype Informed Selection of Hematopoietic Cell Donors Fail to Predict Outcome of Patients With Myelodysplastic Syndromes or Secondary Acute Myeloid Leukemia
by: Johannes Schetelig, et al.
Published: (2021-12-01)

KIR3DL1-Negative CD8 T Cells and KIR3DL1-Negative Natural Killer Cells Contribute to the Advantageous Control of Early Human Immunodeficiency Virus Type 1 Infection in HLA-B Bw4 Homozygous Individuals
by: Xin Zhang, et al.
Published: (2018-08-01)

Fusobacterium nucleatum bacteremia complicated with intracranial Porphyromonas gingivalis and HSV-1 infection: a case report and literature review
by: Sumei Wang, et al.
Published: (2024-02-01)

<p><strong>Uji antibakteri ekstrak daun singkong <em>(manihot esculenta crantz) </em>terhadap <em>fusobacterium nucleatum</em> dan <em>aggregatibacter actinomycetemcomitans </em></p><em><strong>Antibacterial activity test of cassava leaves extract (manihot esculenta crantz) against fusobacterium nucleatum and aggregatibacter actinomycetemcomitans</em></p></strong>
by: Zahara Meilawaty, et al.
Published: (2022-12-01)

<p><strong>Tipe visibilitas <em>foramen mental</em> dengan <em>canalis mandibularis</em> pada radiograf panoramik berdasarkan usia dan perbedaan jenis kelamin</p><em><strong>Visibility type of the mental foramen towards mandibular canal from panoramic radiography according to age and sex</p></em></strong>
by: Larasati Taqulia Hadad, et al.
Published: (2022-12-01)

Eosinophilic oesophagitis
by: Hanna Sikorska-Szaflik
Published: (2016-09-01)

Novel multiplex PCR-SSP method for centromeric KIR allele discrimination
by: Jean-Benoît Le Luduec, et al.
Published: (2018-10-01)

Clinicopathological differences of high Fusobacterium nucleatum levels in colorectal cancer: A review and meta-analysis
by: Yi Wang, et al.
Published: (2022-11-01)

In Vitro evaluation of Licorice Root Ethanolic Extract Antibacterial Activity on Fusobacterium nucleatum in comparison to Chlorhexidine and Doxycycline
by: Mohammadreza Tabatabaeian, et al.
Published: (2023-05-01)

Asociación entre infección por Fusobacterium nucleatum y cáncer colorrectal: un estudio mexicano
by: H. Cuellar-Gómez, et al.
Published: (2022-07-01)

Metagenomic analysis of the fecal microbiome in colorectal cancer patients compared to healthy controls as a function of age
by: Jordan Kharofa, et al.
Published: (2023-02-01)

Diagnostic Performance of Intestinal Fusobacterium nucleatum in Colorectal Cancer: A Meta-Analysis
by: Bo-Jian Peng, et al.
Published: (2018-01-01)

Progress in Fusobacterium nucleatum
by: MAO Xuhu, et al.
Published: (2019-10-01)

Association of Fusobacterium nucleatum infection and colorectal cancer: A Mexican study
by: H. Cuellar-Gómez, et al.
Published: (2022-07-01)

Fusobacterium nucleatum Subspecies Differ in Biofilm Forming Ability in vitro
by: Maria Muchova, et al.
Published: (2022-03-01)